GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
Laura Bertoccini, Marco Giorgio Baroni
Topics & Concepts
Type 2 diabetesPharmacologyMedicineGlucagon-like peptide 1 receptorReceptorDiabetes mellitusChemistryInternal medicineAgonistEndocrinologyDiabetes Treatment and ManagementPancreatic function and diabetesPharmacology and Obesity Treatment